MoneyWorks4Me

Genomic Valley Biotech submits intimation of approval of extension of time for holding AGM

31 Aug 2026 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Genomic Valley Biotech has informed that at the request of the Company, Registrar of Companies, Haryana vide its letter dated 30th August, 2026, has accorded approval for extension of time for holding Annual General Meeting (AGM) of the Company for the financial year ended 31st March, 2026 by 3 months i.e. up to 31st December, 2026, which was earlier due to be held on or before 30th September, 2026. Date of Annual General Meeting will be intimated in due course of time as and when it is decided by the Board of Directors of the Company.

The above information is a part of company’s filings submitted to BSE.
Peers